MassachusettsState Snapshot for Children

In this comparison, the NHQDR measures for Massachusetts for the most recent data year and the baseline year are compared to the average of all States.

Historically, the State Snapshots have included State-specific estimates for selected AHRQ Quality Indicators (QIs) based on Healthcare Cost and Utilization Project (HCUP) data. The 2018 QDR does not include State-specific QI estimates based on 2016 HCUP data because the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System version of the QI software used did not include risk adjustment. State-specific QIs will be reported in future QDRs when the estimates can be risk adjusted.

Measures Better Than Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine Total 2016 90.6 Better than Average 2008 46.9 Average
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine Total 2016 90.3 Better than Average 2008 61.2 Better than Average
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine Total 2016 98.6 Better than Average 2000 96.1 Better than Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine Total 2016 97.0 Better than Average 2000 79.5 Better than Average
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine Total 2016 94.0 Better than Average 2000 87.7 Better than Average
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine Total 2016 96.8 Better than Average 2000 93.3 Better than Average
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2016 96.5 Better than Average 2008 49.8 Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years Total 2016 97.0 Better than Average 2008 32.3 Average
Measures That Are Average in The Recent Year
Measure Population Recent Year Recent Rate Recent Performance Baseline Year Baseline Rate Baseline Performance
Children ages 19-35 months who received 3 or more doses of polio vaccine Total 2016 99.6 Average 2000 94.1 Better than Average
Adolescent males ages 13-15 who received 3 or more doses of human papillomavirus (HPV) vaccine Total 2016 32.9 Average Missing